Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction: An 18-Year Nationwide Experience.

Szummer K, Lindhagen L, Evans M, Spaak J, Koul S, Åkerblom A, Carrero JJ, Jernberg T.

Circ Cardiovasc Qual Outcomes. 2019 Sep;12(9):e005879. doi: 10.1161/CIRCOUTCOMES.119.005879. Epub 2019 Sep 12.

PMID:
31510770
2.

Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1): a target for cancer therapeutic intervention?

Jaiswal PK, Koul S, Palanisamy N, Koul HK.

Cancer Cell Int. 2019 Aug 31;19:224. doi: 10.1186/s12935-019-0947-2. eCollection 2019.

3.

Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study.

Ritsinger V, Jensen J, Ohm D, Omerovic E, Koul S, Fröbert O, Erlinge D, James S, Lagerqvist B, Norhammar A.

Diab Vasc Dis Res. 2019 Nov;16(6):582-584. doi: 10.1177/1479164119871540. Epub 2019 Sep 3.

PMID:
31476896
4.

Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling.

Shishodia G, Koul S, Koul HK.

Prostate. 2019 Nov;79(15):1739-1751. doi: 10.1002/pros.23898. Epub 2019 Aug 26.

PMID:
31449679
5.

Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial.

Wester A, Attar R, Mohammad MA, Andell P, Hofmann R, Jensen J, Szummer K, Erlinge D, Koul S.

J Am Heart Assoc. 2019 Aug 20;8(16):e012741. doi: 10.1161/JAHA.119.012741. Epub 2019 Aug 7.

6.

Effect of IS01957, a para-coumaric acid derivative on pharmacokinetic modulation of diclofenac through oral route for augmented efficacy.

Sharma A, Gour A, Bhatt S, Rath SK, Malik TA, Dogra A, Sangwan PL, Koul S, Abdullah ST, Singh G, Nandi U.

Drug Dev Res. 2019 Jul 18. doi: 10.1002/ddr.21574. [Epub ahead of print]

PMID:
31318064
7.

Peripheral artery disease and outcomes in patients with acute myocardial infarction.

Attar R, Wester A, Koul S, Eggert S, Andell P.

Open Heart. 2019 May 12;6(1):e001004. doi: 10.1136/openhrt-2018-001004. eCollection 2019.

8.

Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART.

Völz S, Angerås O, Koul S, Haraldsson I, Sarno G, Venetsanos D, Grimfärd P, Ulvenstam A, Hofmann R, Hamid M, Henareh L, Wagner H, Jensen J, Danielewicz M, Östlund O, Eriksson P, Scherstén F, Linder R, Råmunddal T, Pétursson P, Fröbert O, James S, Erlinge D, Omerovic E.

Eur Heart J Acute Cardiovasc Care. 2019 Jun 25:2048872618817217. doi: 10.1177/2048872618817217. [Epub ahead of print]

PMID:
31237158
9.

Correction: Antioxidant properties of ALD grown nanoceria films with tunable valency.

Gupta A, Sakthivel TS, Neal CJ, Koul S, Singh S, Kushima A, Seal S.

Biomater Sci. 2019 Jul 1;7(7):3076. doi: 10.1039/c9bm90034a. Epub 2019 Jun 19.

PMID:
31215566
10.

Genetic variant rs10937405 of TP63 and susceptibility to lung cancer risk in north Indian population.

Rasool Bhat GH, Bhat A, Verma S, Sethi I, Shah R, Sharma V, Minerva S, Bakshi D, Sharma B, Koul S, Abrol D, Bhat A, Kumar R.

J Genet. 2019 Jun;98(2). pii: 59.

11.

Antioxidant properties of ALD grown nanoceria films with tunable valency.

Gupta A, Sakthivel TS, Neal CJ, Koul S, Singh S, Kushima A, Seal S.

Biomater Sci. 2019 Jul 1;7(7):3051-3061. doi: 10.1039/c9bm00397e. Epub 2019 May 22. Erratum in: Biomater Sci. 2019 Jun 19;:.

PMID:
31115397
12.

Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned GPI during primary percutaneous coronary intervention in acute myocardial infarction - a VALIDATE-SWEDEHEART substudy.

Sharma T, Rylance R, Karlsson S, Koul S, Venetsanos D, Omerovic E, Fröbert O, Persson J, James S, Erlinge D.

Eur Heart J Cardiovasc Pharmacother. 2019 May 15. pii: pvz015. doi: 10.1093/ehjcvp/pvz015. [Epub ahead of print]

PMID:
31093662
13.

Reactive oxygen species and cancer: A complex interaction.

Saikolappan S, Kumar B, Shishodia G, Koul S, Koul HK.

Cancer Lett. 2019 Jun 28;452:132-143. doi: 10.1016/j.canlet.2019.03.020. Epub 2019 Mar 21.

PMID:
30905813
14.

Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.

Redfors B, Dworeck C, Haraldsson I, Angerås O, Odenstedt J, Ioanes D, Petursson P, Völz S, Albertsson P, Råmunddal T, Persson J, Koul S, Erlinge D, Omerovic E.

Eur Heart J. 2019 Apr 14;40(15):1202-1210. doi: 10.1093/eurheartj/ehz069.

PMID:
30851037
15.

Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement.

Berntorp K, Koul S, Nozohoor S, Harnek J, Bjursten H, Götberg M.

BMC Cardiovasc Disord. 2019 Feb 26;19(1):44. doi: 10.1186/s12872-019-1021-7.

16.

Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.

Rath SK, Singh S, Kumar S, Wani NA, Rai R, Koul S, Khan IA, Sangwan PL.

Bioorg Med Chem. 2019 Jan 15;27(2):343-353. doi: 10.1016/j.bmc.2018.12.008. Epub 2018 Dec 6.

PMID:
30552006
17.

Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013.

Mohammad MA, Karlsson S, Haddad J, Cederberg B, Jernberg T, Lindahl B, Fröbert O, Koul S, Erlinge D.

BMJ. 2018 Dec 12;363:k4811. doi: 10.1136/bmj.k4811.

18.

MicroRNA cluster miR199a/214 are differentially expressed in female and male rats following nicotine self-administration.

Pittenger ST, Schaal VL, Moore D, Guda RS, Koul S, Yelamanchili SV, Bevins RA, Pendyala G.

Sci Rep. 2018 Nov 30;8(1):17464. doi: 10.1038/s41598-018-35747-z.

19.

Association of Weather With Day-to-Day Incidence of Myocardial Infarction: A SWEDEHEART Nationwide Observational Study.

Mohammad MA, Koul S, Rylance R, Fröbert O, Alfredsson J, Sahlén A, Witt N, Jernberg T, Muller J, Erlinge D.

JAMA Cardiol. 2018 Nov 1;3(11):1081-1089. doi: 10.1001/jamacardio.2018.3466.

PMID:
30422202
20.

Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial.

Andell P, Berntorp K, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Venetsanos D, Erlinge D, Fröbert O, Koul S, Reitan C, Götberg M.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):2084-2094. doi: 10.1016/j.jcin.2018.07.035.

PMID:
30336812
21.

Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction.

Erlinge D, Koul S, Omerovic E, Fröbert O, Linder R, Danielewicz M, Hamid M, Venetsanos D, Henareh L, Pettersson B, Wagner H, Grimfjärd P, Jensen J, Hofmann R, Ulvenstam A, Völz S, Petursson P, Östlund O, Sarno G, Wallentin L, Scherstén F, Eriksson P, James S.

Eur Heart J Acute Cardiovasc Care. 2018 Oct 3:2048872618805663. doi: 10.1177/2048872618805663. [Epub ahead of print]

PMID:
30281320
22.

Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction.

Entezarjou A, Mohammad MA, Andell P, Koul S.

Open Heart. 2018 Sep 5;5(2):e000852. doi: 10.1136/openhrt-2018-000852. eCollection 2018.

23.

Synthesis and Biological Evaluation of Novel Osthol Derivatives as Potent Cytotoxic Agents.

Farooq S, Banday JA, Hussain A, Nazir M, Qurishi MA, Hamid A, Koul S.

Med Chem. 2019;15(2):138-149. doi: 10.2174/1573406414666180911161047.

PMID:
30207222
24.

Coronary Hemodynamics in Patients With Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: Implications for Clinical Indices of Coronary Stenosis Severity.

Ahmad Y, Götberg M, Cook C, Howard JP, Malik I, Mikhail G, Frame A, Petraco R, Rajkumar C, Demir O, Iglesias JF, Bhindi R, Koul S, Hadjiloizou N, Gerber R, Ramrakha P, Ruparelia N, Sutaria N, Kanaganayagam G, Ariff B, Fertleman M, Anderson J, Chukwuemeka A, Francis D, Mayet J, Serruys P, Davies J, Sen S.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):2019-2031. doi: 10.1016/j.jcin.2018.07.019. Epub 2018 Aug 25.

25.

Thermal Stability of Hole-Selective Tungsten Oxide: In Situ Transmission Electron Microscopy Study.

Ali H, Koul S, Gregory G, Bullock J, Javey A, Kushima A, Davis KO.

Sci Rep. 2018 Aug 23;8(1):12651. doi: 10.1038/s41598-018-31053-w.

26.

Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.

Escaned J, Ryan N, Mejía-Rentería H, Cook CM, Dehbi HM, Alegria-Barrero E, Alghamdi A, Al-Lamee R, Altman J, Ambrosia A, Baptista SB, Bertilsson M, Bhindi R, Birgander M, Bojara W, Brugaletta S, Buller C, Calais F, Silva PC, Carlsson J, Christiansen EH, Danielewicz M, Di Mario C, Doh JH, Erglis A, Erlinge D, Gerber RT, Going O, Gudmundsdottir I, Härle T, Hauer D, Hellig F, Indolfi C, Jakobsen L, Janssens L, Jensen J, Jeremias A, Kåregren A, Karlsson AC, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Koo BK, Koul S, Laine M, Lehman SJ, Lindroos P, Malik IS, Maeng M, Matsuo H, Meuwissen M, Nam CW, Niccoli G, Nijjer SS, Olsson H, Olsson SE, Omerovic E, Panayi G, Petraco R, Piek JJ, Ribichini F, Samady H, Samuels B, Sandhall L, Sapontis J, Sen S, Seto AH, Sezer M, Sharp ASP, Shin ES, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Varenhorst C, Vinhas H, Vrints CJ, Walters D, Yokoi H, Fröbert O, Patel MR, Serruys P, Davies JE, Götberg M.

JACC Cardiovasc Interv. 2018 Aug 13;11(15):1437-1449. doi: 10.1016/j.jcin.2018.05.029.

27.

Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction.

Mohammad MA, Koul S, Smith JG, Noc M, Lang I, Holzer M, Clemmensen P, Jensen U, Engstrøm T, Arheden H, James S, Lindahl B, Metzler B, Erlinge D.

Am J Cardiol. 2018 Sep 1;122(5):735-743. doi: 10.1016/j.amjcard.2018.05.005. Epub 2018 Jun 5.

PMID:
30049462
28.

Bivalirudin versus heparin with primary percutaneous coronary intervention.

Venetsanos D, Lawesson SS, James S, Koul S, Erlinge D, Swahn E, Alfredsson J.

Am Heart J. 2018 Jul;201:9-16. doi: 10.1016/j.ahj.2018.03.014. Epub 2018 Mar 28.

PMID:
29910059
29.

Periodically Ordered Nanoporous Perovskite Photoelectrode for Efficient Photoelectrochemical Water Splitting.

Shi L, Zhou W, Li Z, Koul S, Kushima A, Yang Y.

ACS Nano. 2018 Jun 26;12(6):6335-6342. doi: 10.1021/acsnano.8b03940. Epub 2018 Jun 18.

PMID:
29897730
30.

Assessment of chemical and genetic variability in Tanacetum gracile accessions collected from cold desert of Western Himalaya.

Mahajan V, Chouhan R, Kitchlu S, Bindu K, Koul S, Singh B, Bedi YS, Gandhi SG.

3 Biotech. 2018 Jun;8(6):284. doi: 10.1007/s13205-018-1299-7. Epub 2018 Jun 2.

31.

No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Koul S, Smith JG, Götberg M, Omerovic E, Alfredsson J, Venetsanos D, Persson J, Jensen J, Lagerqvist B, Redfors B, James S, Erlinge D.

Circ Cardiovasc Interv. 2018 Mar;11(3):e005528. doi: 10.1161/CIRCINTERVENTIONS.117.005528.

PMID:
29870381
32.

Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.

Wang F, Koul S, Shanmugam PST, Dong Q, Koul HK.

Mol Cancer Res. 2018 Sep;16(9):1430-1440. doi: 10.1158/1541-7786.MCR-18-0010. Epub 2018 May 30.

33.

Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis.

Jaiswal PK, Koul S, Shanmugam PST, Koul HK.

Sci Rep. 2018 May 10;8(1):7459. doi: 10.1038/s41598-018-25798-7.

34.

Wastewater: A Potential Bioenergy Resource.

Prakash J, Sharma R, Ray S, Koul S, Kalia VC.

Indian J Microbiol. 2018 Jun;58(2):127-137. doi: 10.1007/s12088-017-0703-z. Epub 2017 Dec 29.

35.

Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21Cip1/Waf1, p27Kip1 and cyclin D1.

Singh K, Dong Q, TimiriShanmugam PS, Koul S, Koul HK.

Cancer Lett. 2018 Jul 1;425:164-173. doi: 10.1016/j.canlet.2018.03.042. Epub 2018 Mar 30.

PMID:
29605511
36.

Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis.

Shishodia G, Koul S, Dong Q, Koul HK.

Mol Cancer Ther. 2018 Jun;17(6):1217-1228. doi: 10.1158/1535-7163.MCT-17-1157. Epub 2018 Mar 16.

37.

Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction: A SWEDEHEART study.

Wester A, Mohammad MA, Andell P, Rylance R, Dankiewicz J, Friberg H, James S, Omerovic E, Erlinge D, Koul S.

Resuscitation. 2018 May;126:172-178. doi: 10.1016/j.resuscitation.2018.01.044. Epub 2018 Feb 2.

PMID:
29410284
38.

Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents.

Farooq S, Hussain A, Qurishi MA, Hamid A, Koul S.

Anticancer Agents Med Chem. 2018;18(11):1531-1539. doi: 10.2174/1871520618666171229222956.

PMID:
29298653
39.

Cyclodipeptide c(Orn-Pro) Conjugate with 4-Ethylpiperic Acid Abrogates Cancer Cell Metastasis through Modulating MDM2.

Shankar S, Faheem MM, Nayak D, Wani NA, Farooq S, Koul S, Goswami A, Rai R.

Bioconjug Chem. 2018 Jan 17;29(1):164-175. doi: 10.1021/acs.bioconjchem.7b00670. Epub 2017 Dec 21.

PMID:
29216716
40.

Nonculprit Stenosis Evaluation Using Instantaneous Wave-Free Ratio in Patients With ST-Segment Elevation Myocardial Infarction.

Thim T, Götberg M, Fröbert O, Nijveldt R, van Royen N, Baptista SB, Koul S, Kellerth T, Bøtker HE, Terkelsen CJ, Christiansen EH, Jakobsen L, Kristensen SD, Maeng M.

JACC Cardiovasc Interv. 2017 Dec 26;10(24):2528-2535. doi: 10.1016/j.jcin.2017.07.021. Epub 2017 Nov 29.

41.

Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention.

Andell P, Sjögren J, Batra G, Szummer K, Koul S.

Eur J Cardiothorac Surg. 2017 Nov 1;52(5):930-936. doi: 10.1093/ejcts/ezx219.

PMID:
29088423
42.

Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART study.

Lindholm D, Alfredsson J, Angerås O, Böhm F, Calais F, Koul S, Lagerqvist B, Renlund H, Sarno G, Varenhorst C.

Eur Heart J Qual Care Clin Outcomes. 2017 Jan 1;3(1):53-60. doi: 10.1093/ehjqcco/qcw044.

PMID:
28927193
43.

Editor's Choice- Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial.

Karlsson S, Andell P, Mohammad MA, Koul S, Olivecrona GK, James SK, Fröbert O, Erlinge D.

Eur Heart J Acute Cardiovasc Care. 2019 Feb;8(1):15-23. doi: 10.1177/2048872617727723. Epub 2017 Sep 1.

PMID:
28862032
44.

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.

Erlinge D, Omerovic E, Fröbert O, Linder R, Danielewicz M, Hamid M, Swahn E, Henareh L, Wagner H, Hårdhammar P, Sjögren I, Stewart J, Grimfjärd P, Jensen J, Aasa M, Robertsson L, Lindroos P, Haupt J, Wikström H, Ulvenstam A, Bhiladvala P, Lindvall B, Lundin A, Tödt T, Ioanes D, Råmunddal T, Kellerth T, Zagozdzon L, Götberg M, Andersson J, Angerås O, Östlund O, Lagerqvist B, Held C, Wallentin L, Scherstén F, Eriksson P, Koul S, James S.

N Engl J Med. 2017 Sep 21;377(12):1132-1142. doi: 10.1056/NEJMoa1706443. Epub 2017 Aug 27.

45.

Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

Grimfjärd P, James S, Persson J, Angerås O, Koul S, Omerovic E, Varenhorst C, Lagerqvist B, Erlinge D.

EuroIntervention. 2017 Dec 20;13(11):1303-1310. doi: 10.4244/EIJ-D-17-00458.

46.

Progressive increase of the Tpeak-Tend interval is associated with ischaemia-induced ventricular fibrillation in a porcine myocardial infarction model.

Azarov JE, Demidova MM, Koul S, van der Pals J, Erlinge D, Platonov PG.

Europace. 2018 May 1;20(5):880-886. doi: 10.1093/europace/eux104.

PMID:
28541470
47.

Sweden: coronary and structural heart interventions from 2010 to 2015.

Witt N, Rück A, James SK, Koul S, Lagerqvist B.

EuroIntervention. 2017 May 15;13(Z):Z70-Z74. doi: 10.4244/EIJ-D-16-00830.

48.

Intravascular Ultrasound Guidance Is Associated With Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared With Angiography Guidance Alone.

Andell P, Karlsson S, Mohammad MA, Götberg M, James S, Jensen J, Fröbert O, Angerås O, Nilsson J, Omerovic E, Lagerqvist B, Persson J, Koul S, Erlinge D.

Circ Cardiovasc Interv. 2017 May;10(5). pii: e004813. doi: 10.1161/CIRCINTERVENTIONS.116.004813.

PMID:
28487356
49.

Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes.

Lettino M, Andell P, Zeymer U, Widimsky P, Danchin N, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Sendón JL, Tousek P, Weidinger F, Weston CFM, Zaman A, Li J, Jukema JW; PIRAEUS group.

Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):198-213. doi: 10.1093/ehjcvp/pvw049.

PMID:
28329196
50.

Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.

Mohammad MA, Andell P, Koul S, Desta L, Jernberg T, Omerovic E, Spaak J, Fröbert O, Jensen J, Engstrøm T, Hofman-Bang C, Persson H, Erlinge D.

EuroIntervention. 2017 Jun 2;13(2):e210-e218. doi: 10.4244/EIJ-D-16-01021.

PMID:
28242589

Supplemental Content

Support Center